Bill · S. 1830· Senate(119-S-1830)
Right to Treat Act
- Introduced
- 5/21/2025
- Last activity
- 3/19/2026 — Committee on Health, Education, Labor, and Pensions. Hearings held.
- Sponsored by
- Ron Johnson
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
This bill is called the "Right to Treat Act." It states that federal agencies, such as the FDA, NIH, and CDC, do not have the power to regulate the practice of medicine. It also prevents federal laws or policies from stopping the prescription or disbursement of FDA-approved drugs for unapproved uses. However, it does not change existing laws or policies regarding abortion, assisted suicide, euthanasia, mercy killing, coercive family planning, female genital mutilation, or gender transition medical interventions.
Yes· 3 of 7
Does this leave more decisions to the states?+8
By removing federal authority over medical practice, it shifts that power back to the states and practitioners.
Does this make health care easier to get in general?+4
Increases physician autonomy to prescribe approved drugs for unapproved uses, potentially expanding treatment options.
Would people over 65 be better off under this?+2
Seniors with complex conditions may benefit from expanded off-label drug use options.
The opposite· 3 of 4
Does this give the federal government more power?-8
The bill explicitly removes the authority of federal agencies to regulate the practice of medicine.
Does this make the country readier for the next outbreak?-4
Removing the authority of the CDC and FDA to regulate medical practice could hinder coordinated public health responses.
Does this give people more protection from unfair business practices?-3
Reducing federal oversight of medical practice may decrease consumer protections regarding standard of care.
Who it would affect, and how
Potential Positive Impacts for People
-
Freedom in Medical Treatment: Section 2(a)(1) removes the authority of federal agencies to regulate the practice of medicine, which limits federal oversight of how doctors treat patients.
-
Expanded Medication Options: Section 2(a)(2) ensures that federal laws or regulations cannot stop the prescription or disbursement of FDA-approved drugs for uses that are not officially approved.
Potential Negative Impacts for People
- Lack of Federal Oversight: Section 2(a)(1) removes the authority of agencies like the FDA, NIH, and CDC to regulate the practice of medicine, which removes federal-level regulation of medical practices.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For People With Disabilities+2Good For Retirees+2Good For Rural Residents+2Good For Seniors+2
- Economy And Finance
- Improves Consumer Protection-3
- Governance And Ideology
- Increase States Rights+8Increases Federal Power-8
- Healthcare
- Improves Healthcare Access+4Improves Mental Health Access+2Improves Pandemic Preparedness-4Improves Opioid Crisis Response-2
- 3/19/2026
- Committee on Health, Education, Labor, and Pensions. Hearings held.
- 5/21/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate